Unknown

Dataset Information

The intravenous and oral pharmacokinetics of lotilaner in dogs.


ABSTRACT:

Background

Lotilaner is a new oral ectoparasiticide from the isoxazoline class developed for the treatment of flea and tick infestations in dogs. It is formulated as pure S-enantiomer in flavoured chewable tablets (Credelio™). The pharmacokinetics of lotilaner were thoroughly determined after intravenous and oral administration and under different feeding regimens in dogs.

Methods

Twenty-six adult beagle dogs were enrolled in a pharmacokinetic study evaluating either intravenous or oral administration of lotilaner. Following the oral administration of 20 mg/kg, under fed or fasted conditions, or intravenous administration of 3 mg/kg, blood samples were collected up to 35 days after treatment. The effects of timing of offering food and the amount of food consumed prior or aft

SUBMITTER: Toutain CE 

PROVIDER: S-EPMC5664907 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature